Signal active
Organization
Contact Information
Overview
May Health develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility, designed to provide patients with a more natural and less medicalised pregnancy experience.
May Health aims to restore ovulation in PCOS patients through a simple, one-time, durable, minimally invasive treatment. May Health's procedure is done transvaginally, under ultrasound guidance, and does not require general anesthesia. The technique can be performed in the clinic setting using the same minimally invasive access commonly used by fertility physicians for IVF.
About
Health Care, Medical Device
2017
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
May Health headquartered in Europe, operates in the Health Care, Medical Device sector. The company focuses on Health Care and has secured $864.6M in funding across 24 round(s). With a team of 1-10 employees, May Health is actively contributing to advancements in Health Care. Their latest funding round, Series B - May Health, raised $24.8M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
5
0
$36.0M
Details
3
May Health has raised a total of $36.0M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2019 | Early Stage Venture | 11.2M | ||
2018 | Seed | |||
2024 | Early Stage Venture | 24.8M |
Investors
May Health is funded by 14 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
May Health | - | FUNDING ROUND - May Health | 24.8M |
Trill Impact | - | FUNDING ROUND - Trill Impact | 24.8M |
May Health | - | FUNDING ROUND - May Health | 24.8M |
Kidron | - | FUNDING ROUND - Kidron | 24.8M |
Recent Activity
There is no recent news or activity for this profile.